Live nieuws • 23h
Scotts Miracle-Gro Beats Q2 Forecasts With Buyback Plan and Eyes US$1 Billion Sales Growth Scotts Miracle-Gro reported Q2 2026 results that were ahead of expectations, with net sales, gross margin and operating income supported mainly by the U.S. Consumer segment.
The company completed the sale of its Hawthorne business to Vireo Growth Inc., receiving shares and warrants and recording related discontinued operations charges.
Management initiated a multi-year share repurchase plan targeting at least one-third of outstanding shares and reaffirmed fiscal 2026 adjusted EPS guidance of US$4.15 to US$4.35, alongside its SMG 2.0 plan aiming for US$1 billion in incremental sales by 2030, driven largely by e-commerce, SKU reductions and AI-driven efficiencies.
The combination of a large buyback program, reaffirmed earnings guidance and a focus on margin structure indicates a management team prioritizing capital returns and operational efficiency.
You should weigh that against execution risks around SKU cuts, e-commerce expansion and the value and liquidity of the Vireo equity received for Hawthorne, as well as the company’s ability to manage commodity and cost pressures into fiscal 2027. Upcoming Dividend • May 15
Upcoming dividend of US$0.66 per share Eligible shareholders must have bought the stock before 22 May 2026. Payment date: 05 June 2026. Payout ratio is a comfortable 74% and this is well supported by cash flows. Trailing yield: 4.7%. Within top quartile of American dividend payers (4.3%). Higher than average of industry peers (1.7%). Aankondiging • May 01
the Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Fiscal 2026 The Scotts Miracle-Gro Company reaffirmed earnings guidance for the fiscal 2026. For the period, the company re-affirmed U.S. Consumer net sales low single-digit growth. New Risk • Apr 30
New major risk - Revenue and earnings growth Earnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Earnings have declined by 19% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Buy Or Sell Opportunity • Apr 28
Now 23% undervalued Over the last 90 days, the stock has risen 4.1% to US$65.38. The fair value is estimated to be US$84.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.6% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 0.5% in 2 years. Earnings are forecast to grow by 69% in the next 2 years. Declared Dividend • Apr 23
First quarter dividend of US$0.66 announced Dividend of US$0.66 is the same as last year. Ex-date: 22nd May 2026 Payment date: 5th June 2026 Dividend yield will be 4.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not adequately covered by earnings (93% earnings payout ratio). However, it is well covered by cash flows (43% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 3.6% to bring the payout ratio under control. EPS is expected to grow by 81% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Aankondiging • Apr 23
The Scotts Miracle-Gro Company to Report Q2, 2026 Results on Apr 29, 2026 The Scotts Miracle-Gro Company announced that they will report Q2, 2026 results Pre-Market on Apr 29, 2026 Aankondiging • Apr 21
The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on June 5, 2026 The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a quarterly cash dividend of $0.66 per share. The dividend is payable on June 5, 2026, to shareholders of record as of May 22, 2026. Buy Or Sell Opportunity • Mar 26
Now 26% undervalued Over the last 90 days, the stock has risen 7.4% to US$62.19. The fair value is estimated to be US$83.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.6% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 0.6% in 2 years. Earnings are forecast to grow by 74% in the next 2 years. Aankondiging • Mar 18
ScottsMiracle-Gro, Bonnie Plants And Gardenuity Launches Inspired To Gro Patio Garden Collection ScottsMiracle-Gro, Bonnie Plants and Gardenuity announced the launch of the Inspired to Gro Patio Garden Collection, a fully integrated gardening experience designed to help new and emerging gardeners grow successfully from day one. Inspired to Gro combines ScottsMiracle-Gro’s plant nutrients, Bonnie Plants’ fully rooted starter plants and Gardenuity’s guided gardening platform – including its curated container garden design, integrated growing components and personalized guidance platform – into a single product offering. This strategic collaboration between three leaders in the lawn and garden industry aims to remove the barriers that have historically prevented millions of interested consumers from starting and sustaining a garden. Inspired to Gro delivers everything needed to plant, grow and thrive in one seamless experience. While millions of Americans express interest in gardening, many struggle with where to begin or how to maintain success over time. Inspired to Gro addresses the barriers. Gardenuity was founded on the belief that gardening should be accessible to everyone, regardless of experience or space. Inspired to Gro removes the uncertainty that keeps so many people from starting by giving them the tools, plants and guided support they need to grow successfully from day one. The launch comes as consumers increasingly prioritize wellness, sustainability and fresh food access, fueling renewed interest in home gardening. Bonnie Plants, which has supplied vegetable and herb plants to American gardeners for more than a century, sees the collaboration as an important step in expanding access to gardening. For more than 100 years, Bonnie Plants has helped people grow their own food at home. Inspired to Gro builds on that legacy by making gardening more approachable and successful for more people. The collection features thoughtfully curated plant selections to support wellness, nourishment and enjoyment. The Inspired to Gro Patio Garden Collection includes three distinct offerings — Everyday Good Seasonal Herb Garden, Well Bloomed Limited Edition Edible Flower and Seasonal Herb Garden and Simply Rooted Seasonal Vegetable and Herb Garden. Inspired to Gro is now available on Amazon, Bonnieplants.com and Gardenuity.com with plans to expand to other ecommerce sites. Each Inspired to Gro garden includes: Gardenuity’s signature 5-gallon, double-stitched grow bag with reinforced handles for optimal root health and durability. Custom-blended soil, formulated specifically for container growing success. Four fully rooted Bonnie Plants selected and aligned to the consumer’s location and seasonal growing conditions. Miracle-Gro Pour & Feed Plant Food to provide essential nutrients to support plant growth and vitality. Grow Pro support from Gardenuity, including personalized guidance and weather-based garden notifications to help ensure ongoing success. Major Estimate Revision • Feb 24
Consensus EPS estimates increase by 15% The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from US$2.80 to US$3.23. Revenue forecast unchanged at US$3.31b. Net income forecast to grow 43% next year vs 44% growth forecast for Chemicals industry in the US. Consensus price target of US$74.00 unchanged from last update. Share price was steady at US$70.52 over the past week. Upcoming Dividend • Feb 13
Upcoming dividend of US$0.66 per share Eligible shareholders must have bought the stock before 20 February 2026. Payment date: 06 March 2026. Payout ratio is on the higher end at 93%, however this is supported by cash flows. Trailing yield: 4.0%. Lower than top quartile of American dividend payers (4.1%). Higher than average of industry peers (1.8%). Aankondiging • Feb 04
Miracle-Gro Introduces Refreshed Lineup of Their Indoor Soils and Plant Foods Miracle-Gro introduced a refreshed lineup of their indoor soils and plant foods. In addition, they are launching new plant care solutions, plus a brand new organic plant food item designed to make indoor gardening an approachable form of self-care, helping people nurture their homes while supporting their well-being. Research shows Americans are nearly twice as likely to report a decline in mood during the winter months (41%) than an improvement (22%). Indoor gardening offers a calming, screen-free way to restore routine, confidence and a sense of progress rooted in care and growth. With simple, intuitive solutions, Miracle-Gro's refreshed indoor assortment removes the guesswork from plant care, making it easy for anyone - from first-time plant parents to seasoned growers - to build a wellness habit that fits seamlessly into everyday life. The updated lineup features over 10 best-selling Miracle-Gro indoor products with clearer, easier-to-shop packaging, designed to reduce decision fatigue and help shoppers quickly find the right solution for their plants. In addition, two new plant care solutions designed to combat pesky insects while beautifying plants, and one new easy-to-use organic plant food solution. Highlights from the refreshed indoor portfolio & new items include: Miracle-Gro Indoor Potting Mixes: Tailored mixes for All Plants, Cactus & Succulent, Tropicals, Orchids and Seed Starting support healthier growth with less guesswork. Miracle-Gro Indoor Plant Foods: Easy-to-use liquid plant foods deliver essential nutrients for stronger, healthier indoor plants. The variety includes All Plants, Cactus &Succulent, Tropicals,Orchids and Plant Food Spikes for All Plants. Miracle-Gro Organic Indoor Plant Food: Made from 94% plant based fertilizer ingredients, this new organic plant food provides instant nourishment for healthier, more resilient plants (vs unfed plants when used as directed). Miracle-Gro Plant Care Flying insect Traps: A sleek, double-sided leaf shaped design that blends seamlessly into plants while quietly capturing flying insects before they can damage roots - protecting both plants and peace of mind. Miracle-Gro Plant Care Leaf Protect & Shine: Gentle on plants and tough on pests, this solution helps protect against common houseplant issues, while beautifying natural leaf shine. Products range from $4.97 - $17.99 and are available at scottsmiraclegro.com and select national retailers, including Amazon, Home Depot, Target and Walmart. Availability may vary by product and retailer. For specific tips and tricks on indoor gardening, you can visit the Miracle-Gro website for helpful blog posts. Declared Dividend • Jan 29
First quarter dividend of US$0.66 announced Dividend of US$0.66 is the same as last year. Ex-date: 20th February 2026 Payment date: 6th March 2026 Dividend yield will be 4.0%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not adequately covered by earnings (93% earnings payout ratio). However, it is covered by cash flows (56% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 3.6% to bring the payout ratio under control. EPS is expected to grow by 60% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Aankondiging • Jan 29
The Scotts Miracle-Gro Company (NYSE:SMG) announces an Equity Buyback for $500 million worth of its shares. The Scotts Miracle-Gro Company (NYSE:SMG) announces a share repurchase program. Under the program, the company will repurchase up to $500 million worth of its shares. The repurchase program has no time limit. Reported Earnings • Jan 29
First quarter 2026 earnings: EPS misses analyst expectations First quarter 2026 results: US$0.83 loss per share (improved from US$1.21 loss in 1Q 2025). Revenue: US$354.4m (down 15% from 1Q 2025). Net loss: US$47.8m (loss narrowed 31% from 1Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 124%. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Aankondiging • Jan 28
The Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Fiscal Year 2026 The Scotts Miracle-Gro Company reaffirmed earnings guidance for the fiscal year 2026. For the year, the company expects U.S. Consumer net sales low single-digit growth. Aankondiging • Jan 27
The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on March 6, 2026 The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on March 6, 2026, to shareholders of record as of February 20, 2026. Aankondiging • Jan 20
The Scotts Miracle-Gro Company to Report Q1, 2026 Results on Jan 28, 2026 The Scotts Miracle-Gro Company announced that they will report Q1, 2026 results at 9:00 AM, Eastern Standard Time on Jan 28, 2026 Aankondiging • Dec 18
The Scotts Miracle-Gro Company, Annual General Meeting, Jan 26, 2026 The Scotts Miracle-Gro Company, Annual General Meeting, Jan 26, 2026. Declared Dividend • Nov 09
Fourth quarter dividend of US$0.66 announced Dividend of US$0.66 is the same as last year. Ex-date: 21st November 2025 Payment date: 5th December 2025 Dividend yield will be 4.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (105% earnings payout ratio). However, it is covered by cash flows (56% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 16% to bring the payout ratio under control. EPS is expected to grow by 62% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • Nov 06
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: US$2.52 (up from US$0.61 loss in FY 2024). Revenue: US$3.41b (down 3.9% from FY 2024). Net income: US$145.2m (up US$180.1m from FY 2024). Profit margin: 4.3% (up from net loss in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Aankondiging • Oct 23
The Scotts Miracle-Gro Company to Report Q4, 2025 Results on Nov 05, 2025 The Scotts Miracle-Gro Company announced that they will report Q4, 2025 results Pre-Market on Nov 05, 2025 Board Change • Sep 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Director Austin Miller was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Aug 15
Upcoming dividend of US$0.66 per share Eligible shareholders must have bought the stock before 22 August 2025. Payment date: 05 September 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Lower than top quartile of American dividend payers (4.5%). Higher than average of industry peers (1.9%). New Risk • Aug 08
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 15% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Minor Risks Dividend is not well covered by earnings (285% payout ratio). Large one-off items impacting financial results. Aankondiging • Aug 06
The Scotts Miracle-Gro Company Announces Changes to Board of Directors The Scotts Miracle-Gro Company announced changes to its Board of Directors. Former U.S. Army Lt. General John R. Vines announced his retirement after more than 12 years on the Board, most recently as a member of the Nominating & Governance and Innovation & Technology committees. His term was set to expire at the 2027 annual meeting of shareholders. Although he no longer is a member of the Board, he will maintain an advisory role as Board member emeritus. Vines served 35 years in the military, commanding the U.S. Army’s XVII Airborne Corps and 27-nation Multi-National Corps in Iraq and the Combined Joint Task Force and 82nd Airborne Division in Afghanistan. Replacing Vines is retired U.S. Army General Scott Miller, who commanded at all grades, most notably as commanding general of the U.S. Army Maneuver Center at Fort Benning and as commander of the Joint Special Operations Command, where he directed U.S. operations in complex geopolitical regions including the Indo-Pacific, Africa, Middle East and South Asia. He also commanded assault forces in Mogadishu, Somalia, during “Blackhawk Down.” His numerous decorations and honors include two awards of the coveted Combat Infantryman Badge, two Purple Hearts, the Silver Star and an unprecedented 20 Overseas Service Bars denoting more than 10 full years in combat zones. In 2023, he was selected as a distinguished graduate of the United States Military Academy and the recipient of the Richard M. Helms Award presented by the CIA Memorial Foundation. In retirement, Miller has pursued an understanding of business serving in both leadership roles and board positions. Through the Miller Advisory Group he consults overseas, speaks on world topics and hosts leadership retreats. He is a senior fellow for the Combating Terrorism Center at the U.S. Military Academy, where he mentors future leaders, and is an ambassador for the nonprofit Shields and Stripes, which is focused on veterans and first responders. Reported Earnings • Aug 01
Third quarter 2025 earnings: EPS in line with expectations, revenues disappoint Third quarter 2025 results: EPS: US$2.58 (up from US$2.33 in 3Q 2024). Revenue: US$1.19b (down 1.2% from 3Q 2024). Net income: US$149.1m (up 13% from 3Q 2024). Profit margin: 13% (up from 11% in 3Q 2024). Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Declared Dividend • Aug 01
Third quarter dividend of US$0.66 announced Dividend of US$0.66 is the same as last year. Ex-date: 22nd August 2025 Payment date: 5th September 2025 Dividend yield will be 4.3%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (285% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 217% to bring the payout ratio under control. EPS is expected to grow by 116% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. Aankondiging • Jul 17
The Scotts Miracle-Gro Company to Report Q3, 2025 Results on Jul 30, 2025 The Scotts Miracle-Gro Company announced that they will report Q3, 2025 results at 9:00 AM, Eastern Standard Time on Jul 30, 2025 Aankondiging • Jun 05
The Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Full Fiscal Year 2025 The Scotts Miracle-Gro Company reaffirmed earnings guidance for the full fiscal year 2025. For the year, the company expects U.S. Consumer net sales low single-digit growth (excluding non-repeat sales for AeroGarden and bulk raw material sales). Upcoming Dividend • May 16
Upcoming dividend of US$0.66 per share Eligible shareholders must have bought the stock before 23 May 2025. Payment date: 06 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Lower than top quartile of American dividend payers (4.7%). Higher than average of industry peers (2.2%). Buy Or Sell Opportunity • May 07
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 21% to US$53.85. The fair value is estimated to be US$68.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.9% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.3% per annum. Earnings are also forecast to grow by 31% per annum over the same time period. Reported Earnings • May 01
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: EPS: US$3.78 (up from US$2.77 in 2Q 2024). Revenue: US$1.42b (down 6.8% from 2Q 2024). Net income: US$217.5m (up 38% from 2Q 2024). Profit margin: 15% (up from 10% in 2Q 2024). Revenue missed analyst estimates by 5.0%. Earnings per share (EPS) also missed analyst estimates by 3.9%. Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Declared Dividend • Apr 24
First quarter dividend of US$0.66 announced Dividend of US$0.66 is the same as last year. Ex-date: 23rd May 2025 Payment date: 6th June 2025 Dividend yield will be 4.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (31% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Aankondiging • Apr 22
The Scotts Miracle-Gro Company Declares Quarterly Dividend, Payable on June 6, 2025 The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on June 6, 2025, to shareholders of record as of May 23, 2025. Aankondiging • Apr 17
The Scotts Miracle-Gro Company to Report Q2, 2025 Results on Apr 30, 2025 The Scotts Miracle-Gro Company announced that they will report Q2, 2025 results Pre-Market on Apr 30, 2025 Aankondiging • Apr 11
An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG). An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG) on April 10, 2025. Under terms of the deal, ScottsMiracle-Gro transferred The Hawthorne Collective to the strategic partner in exchange for an interest-bearing promissory note. The Company retains an option to reacquire The Hawthorne Collective or its assets should cannabis legalization and other measures to positively impact the industry be approved at the federal level.
An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG) on April 10, 2025. Buy Or Sell Opportunity • Mar 28
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 17% to US$54.76. The fair value is estimated to be US$69.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making. Aankondiging • Mar 06
the Scotts Miracle-Gro Company Appoints Martha Stewart as Chief Gardening Officer The Scotts Miracle-Gro Company announced that lifestyle and gardening expert Martha Stewart has joined Miracle-Gro as Chief Gardening Officer. A self-proclaimed 'Dirt Nerd,' Martha is inherently aligned with the mission of Miracle-Gro to get more Americans outside in their gardens and cultivate creativity with their dirt canvases. Martha Stewart will expand her role as the face of the "Gro Like Martha" campaign by collaborating with Miracle-Gro on exclusive content for Miracle-Gro platforms. This new content series, called "GROwing with Martha Stewart," will feature monthly videos, newsletters, and a downloadable calendar with Martha's product recommendations and gardening insights for all skill levels. Additionally, Martha has a new Gardening Handbook set to release on March 18. As Miracle-Gro's Chief Gardening Officer, Martha will serve as a strategic advisor with an eye toward the future of the brand, providing insights based on her experience and acumen in both business and the garden. Aankondiging • Mar 04
The Scotts Miracle-Gro Company Appoints Jim Safka as Senior Vice President of Ecommerce The Scotts Miracle-Gro Company announced that Jim Safka has been named senior vice president of ecommerce. Safka is an accomplished executive with extensive and pioneering experience in technology, marketing and management. He previously served as CEO of Match.com, which grew by more than 20% annually under his leadership. He also ran AT&T Wireless’s ecommerce platform, where under his leadership the digital channel generated significant revenue and profitability increases. Previously, he was CEO of Ask.com, ran a venture portfolio and held key product and marketing roles at E-Trade and Intuit. Most recently, Safka was chief marketing officer at CapConnect+, a financial technology company whose digital marketplace simplifies fixed income issuing and investing. Safka holds a bachelor’s degree from the University of Southern California and earned his master’s in management and marketing from the Kellogg School of Management at Northwestern University. Upcoming Dividend • Feb 14
Upcoming dividend of US$0.66 per share Eligible shareholders must have bought the stock before 21 February 2025. Payment date: 07 March 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 4.0%. Lower than top quartile of American dividend payers (4.5%). Higher than average of industry peers (2.0%). Aankondiging • Feb 01
The Scotts Miracle-Gro Company Appoints Nick Miaritis to Board of Directors The Scotts Miracle-Gro Company announced that Nick Miaritis has been named to its Board of Directors. Miaritis is chief client officer at VaynerMedia, a global creative and media agency, where he leads brand partnerships, accelerates growth opportunities and develops new capabilities. With a passion for crafting culturally relevant content for Fortune 500 brands, he infuses every project with his unique creative vision and strategic edge. Since joining VaynerMedia, he has created leading campaigns, such as Duracell’s “I Buy My Own Batteries” and Planters “Death of Mr. Peanut." Miaritis, a graduate of Georgetown University, is co-founder of the trivia app, FleetWit, and is an advisor to the payments platform Prizeout. He fills the Board seat previously held by Tom Kelly, who retired January 31, 2025, after nearly 20 years as a Board member. Kelly most recently chaired the innovation committee, where he helped guide product strategy and development. The appointment of Miaritis reflects the Board’s focus on adding expanded skills and experiences for fresh perspectives and viewpoints. He is the fifth appointment to the Board since 2022, joining fellow Board members Robert Candelino, Mark Kingdon, Brian Sandoval and Edith Avilés. Recent Insider Transactions Derivative • Jan 31
CEO & Chairman of the Board notifies of intention to sell stock James Hagedorn intends to sell 143k shares in the next 90 days after lodging an Intent To Sell Form on the 30th of January. If the sale is conducted around the recent share price of US$71.56, it would amount to US$10m. For the year to September 2018, James' total compensation was 8% salary and 92% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, James' direct individual holding has increased from 48.06k shares to 73.96k. Company insiders have collectively sold US$2.4m more than they bought, via options and on-market transactions in the last 12 months. Declared Dividend • Jan 30
First quarter dividend of US$0.66 announced Dividend of US$0.66 is the same as last year. Ex-date: 21st February 2025 Payment date: 7th March 2025 Dividend yield will be 3.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (26% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Reported Earnings • Jan 29
First quarter 2025 earnings: EPS and revenues exceed analyst expectations First quarter 2025 results: US$1.21 loss per share (improved from US$1.42 loss in 1Q 2024). Revenue: US$416.8m (up 1.6% from 1Q 2024). Net loss: US$69.5m (loss narrowed 14% from 1Q 2024). Revenue exceeded analyst estimates by 6.3%. Earnings per share (EPS) also surpassed analyst estimates by 1.2%. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Aankondiging • Jan 28
the Scotts Miracle-Gro Company Announces Quarterly Dividend, Payable on March 7, 2025 The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The
dividend is payable on March 7, 2025, to shareholders of record as of February 21, 2025. Aankondiging • Jan 15
The Scotts Miracle-Gro Company to Report Q1, 2025 Results on Jan 29, 2025 The Scotts Miracle-Gro Company announced that they will report Q1, 2025 results Pre-Market on Jan 29, 2025 Aankondiging • Dec 20
The Scotts Miracle-Gro Company, Annual General Meeting, Jan 27, 2025 The Scotts Miracle-Gro Company, Annual General Meeting, Jan 27, 2025. Recent Insider Transactions • Dec 08
CEO & Chairman of the Board recently sold US$1.4m worth of stock On the 4th of December, James Hagedorn sold around 18k shares on-market at roughly US$75.68 per share. This transaction amounted to 20% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was James' only on-market trade for the last 12 months. Recent Insider Transactions Derivative • Dec 05
CEO & Chairman of the Board notifies of intention to sell stock James Hagedorn intends to sell 18k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of December. If the sale is conducted around the recent share price of US$75.68, it would amount to US$1.4m. For the year to September 2018, James' total compensation was 6% salary and 94% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since December 2023, James' direct individual holding has increased from 39.03k shares to 90.34k. Company insiders have collectively sold US$692k more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Nov 07
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: US$0.61 loss per share (improved from US$6.79 loss in FY 2023). Revenue: US$3.55b (flat on FY 2023). Net loss: US$34.9m (loss narrowed 91% from FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings. Aankondiging • Oct 23
The Scotts Miracle-Gro Company to Report Q4, 2024 Results on Nov 06, 2024 The Scotts Miracle-Gro Company announced that they will report Q4, 2024 results Pre-Market on Nov 06, 2024 Price Target Changed • Oct 16
Price target increased by 7.8% to US$88.86 Up from US$82.43, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of US$89.84. Stock is up 80% over the past year. The company is forecast to post earnings per share of US$1.44 next year compared to a net loss per share of US$6.79 last year. Upcoming Dividend • Aug 16
Upcoming dividend of US$0.66 per share Eligible shareholders must have bought the stock before 23 August 2024. Payment date: 06 September 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.7%. Lower than top quartile of American dividend payers (4.5%). Higher than average of industry peers (2.3%). Price Target Changed • Aug 02
Price target increased by 7.6% to US$81.00 Up from US$75.29, the current price target is an average from 7 analysts. New target price is 13% above last closing price of US$71.66. Stock is up 29% over the past year. The company is forecast to post earnings per share of US$1.47 next year compared to a net loss per share of US$6.79 last year. Declared Dividend • Aug 02
Third quarter dividend of US$0.66 announced Dividend of US$0.66 is the same as last year. Ex-date: 23rd August 2024 Payment date: 6th September 2024 Dividend yield will be 3.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (16% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Reported Earnings • Aug 01
Third quarter 2024 earnings: EPS exceeds analyst expectations Third quarter 2024 results: EPS: US$2.33 (up from US$0.78 in 3Q 2023). Revenue: US$1.20b (up 7.5% from 3Q 2023). Net income: US$132.1m (up 202% from 3Q 2023). Profit margin: 11% (up from 3.9% in 3Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 17%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance. Aankondiging • Jul 31
The Scotts Miracle-Gro Company Announces Quarterly Dividend Payment, Payable on September 6, 2024 The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on September 6, 2024, to shareholders of record as of August 23, 2024. Buy Or Sell Opportunity • Jul 17
Now 21% overvalued Over the last 90 days, the stock has fallen 1.1% to US$67.24. The fair value is estimated to be US$55.71, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 15% over the last 3 years. Meanwhile, the company became loss making. 
